000			01752 a2200469 4500
005			20250518091059.0
264		0	_c20210203
008			202102s 0 0 eng d
022			_a1950-6007
024	7		_a10.1016/j.biopha.2020.110054 _2doi
040			_aNLM _beng _cNLM
100	1		_aHsu, Li-Cho
245	0	0	_aBeneficial effect of fluoxetine on anti-tumor progression on hepatocellular carcinoma and non-small cell lung cancer bearing animal model. _h[electronic resource]
260			_bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _cJun 2020
300			_a110054 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdjuvants, Pharmaceutic
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aApoptosis Regulatory Proteins _xmetabolism
650	0	4	_aCarcinoma, Hepatocellular _xprevention & control
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xprevention & control
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aFluoxetine _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aLiver _xdrug effects
650	0	4	_aLiver Neoplasms _xprevention & control
650	0	4	_aLung _xdrug effects
650	0	4	_aLung Neoplasms _xprevention & control
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Nude
650	0	4	_aSignal Transduction
700	1		_aTu, Hsi-Feng
700	1		_aHsu, Fei-Ting
700	1		_aYueh, Po-Fu
700	1		_aChiang, I-Tsang
773	0		_tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _gvol. 126 _gp. 110054
856	4	0	_uhttps://doi.org/10.1016/j.biopha.2020.110054 _zAvailable from publisher's website
999			_c30716200 _d30716200